CSIMarket Company Name, Ticker, Customers, else..
 
Elite Pharmaceuticals Inc   (ELTP)
 

Elite Pharmaceuticals Inc's Suppliers Performance

ELTP's Supply Chain



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 
ELTP Costs vs Sales of Suppliers Growth Elite Pharmaceuticals Inc recorded an increase in cost of sales by 57.06 % year on year, relative to one quarter ago cost of sales fell by -5.65 % in Q1.

• More on ELTP Suppliers



Elite Pharmaceuticals Inc recorded increase in cost of sales by 57.06 % year on year, compare to one quarter ago cost of sales fell by -5.65 % in Q1.

• More on ELTP Suppliers




Elite Pharmaceuticals Inc's Comment on Supply Chain


The company sources a significant portion of its raw materials from over 20 foreign suppliers, with some materials obtained from only one or a limited number of suppliers. This sourcing strategy involves risks including transportation disruptions, political and economic instability, price volatility, and legal uncertainties. The FDA requires identification of raw material suppliers for drug approval, and changing suppliers may delay manufacturing. The company has acquired pharmaceutical manufacturing equipment and registered its facilities with the FDA and DEA.

Elite Pharmaceuticals Inc's Comment on Supply Chain


The company sources a significant portion of its raw materials from over 20 foreign suppliers, with some materials obtained from only one or a limited number of suppliers. This sourcing strategy involves risks including transportation disruptions, political and economic instability, price volatility, and legal uncertainties. The FDA requires identification of raw material suppliers for drug approval, and changing suppliers may delay manufacturing. The company has acquired pharmaceutical manufacturing equipment and registered its facilities with the FDA and DEA.







ELTP's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Elite Pharmaceuticals Inc 278.78 140.13 56.67 65
SUBTOTAL 0.00 0.00 0.00 -


Sources: Elite Pharmaceuticals Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Elite Pharmaceuticals Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.